Pierre Bordigoni
About
In The Last Decade
Pierre Bordigoni
197 papers receiving 7.8k citations
Peers
Comparison fields: 5 of 127
- Hematology 3.7k
- Immunology 2.1k
- Oncology 1.9k
- Public Health, Environmental and Occupational Health 1.3k
- Epidemiology 1.3k
Countries citing papers authored by Pierre Bordigoni
This map shows the geographic impact of Pierre Bordigoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bordigoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bordigoni more than expected).
Fields of papers citing papers by Pierre Bordigoni
This network shows the impact of papers produced by Pierre Bordigoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bordigoni. The network helps show where Pierre Bordigoni may publish in the future.
Co-authorship network of co-authors of Pierre Bordigoni
This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Bordigoni. A scholar is included among the top collaborators of Pierre Bordigoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Bordigoni. Pierre Bordigoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 360 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | 31 | |
| 8 | 32 | |
| 9 | 30 | |
| 10 | Standards, Options et Recommandations pour la nutrition artificielle au cours et au décours de la greffe de cellules souches hématopoïétiques (CSH) | 3 |
| 11 | 22 | |
| 12 | Les infections à adénovirus en milieu hospitalier | 0 |
| 13 | 112 | |
| 14 | 5 | |
| 15 | 22 | |
| 16 | 47 | |
| 17 | Intérêt des hautes doses de cytosine-arabinoside dans le traitement des leucémies aiguës résistantes. | 1 |
| 18 | [High-dose Cytosine-arabinoside for the Treatment of Resistant Acute-leukemia] | 2 |
| 19 | [Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients]. | 5 |
| 20 | Site fragile sur le chromosome 2 (q11) dans un cas de lymphohistiocytose familiale. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.